Funding Opportunity Title Innovation Award: Minority Health and Health Equity (U01) Clinical Trials Optional

The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity research.Areas of interest include:Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical

credit:


trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $3,000,000


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Funding Opportunity Announcement

Additional Information of Eligibility:
PIO's

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-22-005.html

Contact:


Agency Email Description:
Grant Specialist Email

Agency Email:


Date Posted:
2022-03-31

Application Due Date:


Archive Date:
2022-07-06


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


Uniformed Services University Medical Research Projects | Benjamin Gilman International Scholarship | Automated Flood Warning Systems (AFWS) | Direct Housing_Natural Disaster Loans and Grants | Flood Control Projects |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders